Tran Daniel T, Youn Justin J, Thompson Gary
Internal Medicine, Loma Linda University School of Medicine, Loma Linda, USA.
Ophthalmology, Loma Linda University School of Medicine, Loma Linda, USA.
Cureus. 2025 May 13;17(5):e84040. doi: 10.7759/cureus.84040. eCollection 2025 May.
Hemoglobin SC disease (HbSC) is a sickle cell disease (SCD) that is considered to be mild compared to Hemoglobin SS (HbSS) disease. Both HbSS and HbSC can present with classic SCD complications such as hemolytic anemia, vaso-occlusive complications, functional aplenia, avascular necrosis, and cholelithiasis; however, HbSC generally has less severe and less frequent complications and can often be asymptomatic. As a result, HbSC is often underdiagnosed until a patient presents with a clinically significant complication. We present a case of newly diagnosed HbSC presenting with potentially life-threatening acute cholangitis due to choledocholithiasis. This case report serves to demonstrate that serious complications can occur in patients with HbSC. Additionally, early screening and diagnosis of HbSC in high-risk patients may allow for earlier treatment and potentially reduce the incidence of complications and increase patient quality of life.
血红蛋白SC病(HbSC)是一种镰状细胞病(SCD),与血红蛋白SS(HbSS)病相比,被认为症状较轻。HbSS和HbSC都可能出现典型的SCD并发症,如溶血性贫血、血管闭塞性并发症、功能性无脾、缺血性坏死和胆石症;然而,HbSC通常并发症较轻且较少见,并且常常没有症状。因此,HbSC常常在患者出现具有临床意义的并发症之前未被诊断出来。我们报告一例新诊断的HbSC患者,因胆总管结石出现了可能危及生命的急性胆管炎。本病例报告旨在证明HbSC患者可能发生严重并发症。此外,对高危患者进行HbSC的早期筛查和诊断可能有助于早期治疗,并有可能降低并发症的发生率,提高患者生活质量。